Supplementary Table S5 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

<p>RNA-Seq Variant calling</p>

Guardado en:

Detalles Bibliográficos
Autor principal:	Andrés Elía (15055031) (author)
Otros Autores:	Leo Saldain (15055034) (author), Silvia I. Vanzulli (15055037) (author), Luisa A. Helguero (15055040) (author), Caroline A. Lamb (14947288) (author), Victoria Fabris (15055043) (author), Gabriela Pataccini (15055046) (author), Paula Martínez-Vazquez (15055049) (author), Javier Burruchaga (15055052) (author), Ines Caillet-Bois (15055055) (author), Eunice Spengler (15055058) (author), Gabriela Acosta Haab (15055061) (author), Marcos Liguori (15055064) (author), Alejandra Castets (15055067) (author), Silvia Lovisi (15055070) (author), María F. Abascal (15055073) (author), Virginia Novaro (15055076) (author), Jana Sánchez (15055079) (author), Javier Muñoz (15055082) (author), José M. Belizán (15055085) (author), Martín C. Abba (14947131) (author), Hugo Gass (15055088) (author), Paola Rojas (10737201) (author), Claudia Lanari (14947294) (author)
Publicado:	2025
Materias:	Cancer Tumor Biology Clinical Research and Trials Breast Cancer Clinical Trial Results Phase II clinical trials Endocrinology Hormone signaling and inhibitors
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares